UCSF research shows psychedelics like psilocybin may treat depression, Parkinson’s, and addiction, offering new hope in ...

Northwell Health is conducting a clinical trial to address treatment-resistant depression using similar technology used to treat neurological diseases like Parkinson’s in an effort to seek options for ...

Learn more about a clinical trial examining a potential new treatment for depression in adult patients. Managing symptoms of depression can feel overwhelming, but you are not alone. If you experience ...

Less-common depression treatments, including transcranial magnetic stimulation, ketamine, and esketamine, can boost the effectiveness of antidepressant medications.

"Ayahuasca-derived DMT study shows positive effects on depression therapy in trials" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

GH Research PLC (NASDAQ:GHRS) is among the best psychedelic stocks to buy in 2026. The company is advancing efforts to develop psychedelic medicines targeting conditions like depression, bipolar II ...

For many people, depression does not feel like dramatic despair. It feels like heaviness; like waking up already exhausted by a day that hasn't yet begun. “And depression doesn’t just affect mood, it ...

The researchers found that individuals with depression were about 2.5 times more likely to be diagnosed with epilepsy at a later point. HealthDay News — People with newly diagnosed epilepsy and a ...